Skip to main content

Table 3 Multivariate analysis of prognostic factors of BC

From: Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification

Variable Hazard ratio 95%CI P-value
Age(>60/≤60) 2.278 (1.453,3.571) 0.000
HER2(Positive / Negative) 0.804 (0.405,1.597) 0.533
ER(Positive/Negative) 1.015 (0.507,2.032) 0.966
PR(Positive/Negative) 0.618 (0.330,1.154) 0.131
Tumor size(T2-T4/T1) 1.238 (0.548,2.800) 0.608
Lymph Node metastasis(Yes/No) 1.630 (0.959,2.770) 0.071
Distant metastasis(Yes/No) 3.427 (1.665,7.055) 0.001
Clinical stage(II-IV/I) 1.140 (0.386,3.369) 0.813
ZNF132 expression(High/Low) 1.129 (0.728,1.753) 0.587